Showing results (51-60 of 58) with videos related to
Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Biomedicines|July 27, 2024
Enhancing Neoadjuvant Virotherapy's Effectiveness by Targeting Stroma to Improve Resectability in Pancreatic CancerKhandoker Usran Ferdous, Mulu Z Tesfay, Aleksandra Cios, et al.Frontiers in Oncology|December 2, 2022
Repurposing live attenuated trivalent MMR vaccine as cost-effective cancer immunotherapyYuguo Zhang, Musa Gabere, Mika A Taylor, et al.Biorxiv : the Preprint Server for Biology|September 26, 2025
Pancreatic tumor microenvironment reprogramming via alloantigenexpressing virotherapy elicits tumor rejection and improves immunotherapy responseMulu Z Tesfay, Aleksandra Cios, Zetao Cheng, et al.Nature Communications|October 15, 2020
Th17-inducing autologous dendritic cell vaccination promotes antigen-specific cellular and humoral immunity in ovarian cancer patientsMatthew S Block, Allan B Dietz, Michael P Gustafson, et al.Journal for Immunotherapy of Cancer|May 12, 2026
Pancreatic tumor microenvironment reprogramming via alloantigen-expressing virotherapy elicits tumor rejection and improves immunotherapy responseMulu Z Tesfay, Aleksandra Cios, Zetao Cheng, et al.Frontiers in Immunology|October 27, 2025
Multimodal reprogramming of the tumor microenvironment by MMR and dual checkpoint blockade in hepatocellular carcinoma modelsMulu Z Tesfay, Aleksandra Cios, Khandoker Usran Ferdous, et al.Hepatology (Baltimore, Md.)|September 2, 2022
Characterization of Morreton virus as an oncolytic virotherapy platform for liver cancersBolni Marius Nagalo, Yumei Zhou, Emilien J Loeuillard, et al.Molecular Therapy. Oncology|January 6, 2025
Enhancing immune response and survival in hepatocellular carcinoma with novel oncolytic Jurona virus and immune checkpoint blockadeMulu Z Tesfay, Yuguo Zhang, Khandoker U Ferdous, et al.Pageof 6